John Paul Johnson - 17 Aug 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role: Chief Financial Officer
Signature: Jonathan Weinberg, Attorney-in-fact
Issuer symbol: EVH
Transactions as of: 17 Aug 2022
Net transactions value: -$628,784
Form type: 4
Filing time: 18 Aug 2022, 18:04:57 UTC
Previous filing: 04 Mar 2022
Next filing: 23 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVH	Class A Common Stock	Sale	$628,784	-18,434	-9.9%	$34.11	168,329	17 Aug 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.11 to $34.22, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.11 to $34.22, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.